PIKE PHARMA GMBH

corporate_fareorganization

Country: Switzerland

PIKE PHARMA GMBH

- Funding / Projects
  (4)

4 Projects, page 1 of 1

FLUINHIBIT (Small Molecule Inhibitors of the Trimeric Influenza Virus Polymerase Complex)
assignment_turned_inProject2008 - 2010Partners:INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH, UNISI, PIKE PHARMA GMBH, Vilnius University, HZI +1 partners
INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH,
UNISI,
PIKE PHARMA GMBH,
Vilnius University,
HZI,
University Medical Center Freiburg
Funder: European Commission Project Code: 201634
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
FLUCURE (Development of novel antiviral drugs against Influenza)
Open Access Mandate for Publications assignment_turned_inProject2010 - 2014Partners:University Medical Center Freiburg, BEACTICA THERAPEUTICS AB, Vilnius University, Vironova (Sweden), VUA +4 partners
University Medical Center Freiburg,
BEACTICA THERAPEUTICS AB,
Vilnius University,
Vironova (Sweden),
VUA,
PIKE PHARMA GMBH,
PHARMACELSUS GMBH,
INSTITUTE OF ORGANIC CHEMISTRY WITH CENTRE OF PHYTOCHEMISTRY - BULGARIAN ACADEMY OF SCIENCES,
UNISI
Funder: European Commission Project Code: 259972
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
EUVIRNA (European Training Network on (+)RNA Virus Replication and Antiviral Drug Development)
assignment_turned_inProject2011 - 2015Partners:PIKE PHARMA GMBH, LUMC, University Hospital Heidelberg, KUL, STICHTING RADBOUD UNIVERSITEIT +6 partners
PIKE PHARMA GMBH,
LUMC,
University Hospital Heidelberg,
KUL,
STICHTING RADBOUD UNIVERSITEIT,
Utrecht University,
RIBOXX,
JANSSEN DI,
ARATANA THERAPEUTICS NV,
Cardiff University,
AMU
Funder: European Commission Project Code: 264286
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
SILVER (Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses)
Open Access Mandate for Publications assignment_turned_inProject2010 - 2015Partners:KUL, CISTIM, University Hospital Heidelberg, UNIMI, Leipzig University +20 partners
KUL,
CISTIM,
University Hospital Heidelberg,
UNIMI,
Leipzig University,
LUMC,
SIMM,
AMU,
University of Lübeck,
FU,
STICHTING RADBOUD UNIVERSITEIT,
ERASMUS MC,
CNRS,
PIKE PHARMA GMBH,
Institut Pasteur,
UST,
KRICT,
UOXF,
University of Innsbruck,
Utrecht University,
CSIC,
NCU,
RIBOXX,
UH,
GPhL
Funder: European Commission Project Code: 260644
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

PIKE PHARMA GMBH

PIKE PHARMA GMBH

4 Projects, page 1 of 1

FLUINHIBIT (Small Molecule Inhibitors of the Trimeric Influenza Virus Polymerase Complex)

FLUCURE (Development of novel antiviral drugs against Influenza)

EUVIRNA (European Training Network on (+)RNA Virus Replication and Antiviral Drug Development)

SILVER (Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses)

Loading